Ticker
Unknown company
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK Drugmaker Bristol-Myers Squibb Company (NYSE:BMY) is putting real money behind its confidence in American manufacturing. On August 10, the company said it wi... Drugmaker Bristol-Myers Squibb Company (NYSE:BMY) is putting real money behind its confidence in American manufacturing. On August 10, the company said it will spend about $2.3 billion on a new plant… [+3898 chars]
Source ↗Eli Lilly’s (LLY) Growth Story Keeps Adding Chapters On August 5, Eli Lilly (NYSE:LLY) told investors its second quarter delivered 48% revenue growth, and the days since have brought even more good news. A UK r... On August 5, Eli Lilly (NYSE:LLY) told investors its second quarter delivered 48% revenue growth, and the days since have brought even more good news. A UK regulatory approval, a new Medicare access … [+4238 chars]
Source ↗Eli Lilly’s Weight-Loss Pill Just Got Its First Foothold in Europe Eli Lilly and Company (NYSE:LLY) cleared a notable regulatory hurdle on August 10, when Britain’s drug regulator authorized the company’s oral GLP-1 drug orf... Eli Lilly and Company (NYSE:LLY) cleared a notable regulatory hurdle on August 10, when Britain's drug regulator authorized the company's oral GLP-1 drug orforglipron, becoming the first country in E… [+4221 chars]
Source ↗Can Veeva Systems Inc. (VEEV)’s AI Platform Keep Pace With Eli Lilly and Company (LLY)’s Explosive Growth On August 11, Veeva Systems Inc. (NYSE:VEEV) announced that Eli Lilly and Company (NYSE:LLY) committed to deploying Veeva Vault CRM globally. Vault CRM serve... On August 11, Veeva Systems Inc. (NYSE:VEEV) announced that Eli Lilly and Company (NYSE:LLY) committed to deploying Veeva Vault CRM globally. Vault CRM serves as the core infrastructure for "agentic … [+4457 chars]
Source ↗Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market? The duopoly dominating the multi-billion-dollar GLP-1 weight-loss market has moved from pharmacy shelves to the federal courtroom. Novo Nordisk A/S (NYSE:NVO... The duopoly dominating the multi-billion-dollar GLP-1 weight-loss market has moved from pharmacy shelves to the federal courtroom. Novo Nordisk A/S (NYSE:NVO) filed a lawsuit in U.S. District Court i… [+6998 chars]
Source ↗Eli Lilly vs. Novo Nordisk: Which Company Is Better Positioned for America’s New Drug Manufacturing Policies? For years, investors have viewed Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) through one lens: the race to dominate the booming obesity-drug market. But... For years, investors have viewed Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) through one lens: the race to dominate the booming obesity-drug market. But Washington is beginning to shift the conv… [+7312 chars]
Source ↗Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat? The obesity-drug market has largely been viewed as a race between clinical innovation and commercial execution. Investors have spent the past three years com... The obesity-drug market has largely been viewed as a race between clinical innovation and commercial execution. Investors have spent the past three years comparing prescription growth, market share, … [+8465 chars]
Source ↗Eli Lilly (LLY) Posts Blowout Growth And Raises Its Outlook Eli Lilly (NYSE:LLY) delivered a quarter that forced Wall Street to catch up to its own numbers. On August 5, the company reported second-quarter revenue of... Eli Lilly (NYSE:LLY) delivered a quarter that forced Wall Street to catch up to its own numbers. On August 5, the company reported second-quarter revenue of $23.0 billion, up 48% from a year earlier,… [+4101 chars]
Source ↗Eli Lilly’s Obesity Drugs Drive Massive Revenue Growth In this week’s edition of InnovationRx, we look at Lilly’s 2Q earnings, a cannabis-derived drug for PTSD, Apnimed’s IPO and more In this weeks edition of InnovationRx, we look at Lillys 2Q earnings, a cannabis-derived drug for PTSD, Apnimeds IPO and more. To get it in your inbox, subscribe here. Eli Lilly CEO David Ricks Get… [+3037 chars]
Source ↗'Godzilla' weight-loss shot that's more powerful than Ozempic set to be offered to some patients ahead of FDA approval: Find out if you're eligible Eli Lilly announced Monday a limited number of patients can apply for early access to the weight-loss shot retatrutide, ahead of FDA approval. Obese patients who struggle to slim down on today's blockbuster weight-loss shots are set to be offered retatrutide, an experimental drug that helped patients lose up to a quarter of their body weigh… [+4176 chars]
Source ↗Is Eli Lilly (LLY) Still the Undisputed Leader in the $150 Billion Obesity Drug Market? Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to... Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Health Care Fund".A copy of the letter is available todownload here. The Fund gained 11.99% during… [+3958 chars]
Source ↗GLP-1 battle heats up again as Novo claws its way back into race with Lilly The two pharmaceutical giants are locked in a fierce battle for dominance in the burgeoning obesity drug market Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financia… [+5211 chars]
Source ↗Claude AI Disagrees With President Trump on Eli Lilly (LLY) President Donald Trump recently praised Eli Lily at a public event and called it “a great company” and highlighted its planned $3.5 billion investment for a... President Donald Trump recently praised Eli Lily at a public event and called it "a great company" and highlighted its planned $3.5 billion investment for a manufacturing plant in Pennsylvania. Howe… [+4356 chars]
Source ↗Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal Eli Lilly will acquire AtaiBeckley for up to $3.8 billion. This deal aims to develop psychedelic treatments for depression and other mental health issues. The acquisition includes AtaiBeckley's lead candidate, BPL-003, a nasal spray. This move follows increas… Eli Lilly will buy AtaiBeckley for up to $3.8 billion, the company said on Thursday, joining a race among pharma majors to develop psychedelic treatments for depression and other mental health disord… [+1862 chars]
Source ↗Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal July 16 () - Eli Lilly will buy AtaiBeckley for up to $3.8 billion, the company said on Thursday, joining a race among pharma majors to develop psychedelic... July 16 (Reuters) - Eli Lilly will buy AtaiBeckley for up to $3.8 billion, the company said on Thursday, joining a race among pharma majors to develop psychedelic treatments for depression and other … [+1964 chars]
Source ↗Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and MDMA. Eli Lilly will acquire psychedelic drugmaker AtaiBeckley for $2.8 billion up front, the company said Thursday, as momentum grows for using versions of the drugs as mental health treatments. The tra… [+1605 chars]
Source ↗Eli Lilly and Company (LLY) Fell on Regulatory And Pricing Policy Challenges RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q1 2026 inves... RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its "RiverPark Large Growth Fund" Q1 2026 investor letter. A copy of the letter can be do… [+4672 chars]
Source ↗Eli Lilly and Company (LLY) Up More Than 6% Over the Past Month, Can it Move Higher? Eli Lilly and Company (NYSE:LLY) is one of the Stocks That Will Make You Rich Over the Next 3 Years. Eli Lilly and Company (NYSE:LLY) has gained roughly 6% o... Eli Lilly and Company (NYSE:LLY) is one of the Stocks That Will Make You Rich Over the Next 3 Years. Eli Lilly and Company (NYSE:LLY) has gained roughly 6% over the past 30 days, and the Street expec… [+1953 chars]
Source ↗Is Eli Lilly and Company (LLY) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds? Eli Lilly and Company (NYSE:LLY) is among the Best Healthcare Stocks Stocks. On June 23, Reuters reported that Eli Lilly and Company (NYSE:LLY) expects to la... Eli Lilly and Company (NYSE:LLY) is among the Best Healthcare Stocks Stocks.On June 23, Reuters reported that Eli Lilly and Company (NYSE:LLY) expects to launch its oral weight-loss drug across Europ… [+1946 chars]
Source ↗Eli Lilly (LLY) and BioArctic AB Enter into Research and Collaboration Agreement Eli Lilly and Company (NYSE:LLY) is one of the top trending US stocks to buy now. Eli Lilly and Company (NYSE:LLY) and BioArctic AB announced on June 22 thei... Eli Lilly and Company (NYSE:LLY) is one of the top trending US stocks to buy now. Eli Lilly and Company (NYSE:LLY) and BioArctic AB announced on June 22 their entry into a research and collaboration … [+1735 chars]
Source ↗Trump name-dropped Nokia and Eli Lilly in a Pennsylvania speech. Here's what happened to 5 other stocks he singled out Trump’s children have been buying and selling stock on his behalf while he’s in office, posing a legal quagmire. Andrew Harnik/Getty Images As President Donald Trump stood on a podium in Pennsylvania's Lehigh Valley, he went apparently off script to name check a pair of companies (1). Pharmaceutical giant Eli … [+4721 chars]
Source ↗Nancy Pelosi Stock Tracker Flags Eli Lilly, Nokia After Trump Praise: ‘Keep An Eye On These Two’ If you click 'Accept all', we and our partners, including 247 who are part of the IAB Transparency & Consent Framework, will also store and / or access information on a device (in other words, us… [+1046 chars]
Source ↗Eli Lilly and Company (LLY) – Among the 10 Reliable Dividend Stocks to Buy for Long-Term Investors Eli Lilly and Company (NYSE:LLY) is included among the 10 Reliable Dividend Stocks to Buy for Long-Term Investors. On June 23, Reuters reported that Eli Lill... Eli Lilly and Company (NYSE:LLY) is included among the 10 Reliable Dividend Stocks to Buy for Long-Term Investors. Eli Lilly and Company (LLY) - Among the 10 Reliable Dividend Stocks to Buy for Long… [+2132 chars]
Source ↗Abbisko Teams Up With Lilly In Latest U.S.-China Pharma Collaboration Strategic research collaboration and license agreement is worth up to $1.9 billion to Abbisko David Ricks, chief executive officer of Eli Lilly & Co., speaks during the China Development Forum in Beijing in March this year. Photographer: Qilai Shen/Bloomberg © 2026 Bloomberg Finance LP … [+3873 chars]
Source ↗Did Trump Get Early Access to Eli Lilly’s New Weight-Loss Drug? Did Trump get early access to Eli Lilly’s weight-loss drug? The FDA let one 79-year-old take an experimental obesity treatment. The mystery patient sounds a lot like Trump, but let’s examine the evidence. When it comes to Donald Trumps health, theres always another mystery. The president regularly appears to nod off during meetings, and hes frequently spotted with a makeup-covered hand bruise and othe… [+8434 chars]
Source ↗No disclosed trades for $LLY.